Dr. Schnaus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
420 Delaware St SE
Ste MMC284
Minneapolis, MN 55455Phone+1 612-626-5031Fax+1 612-625-3238
Education & Training
University of MinnesotaResidency, Internal Medicine, 2014 - 2017
University of South Florida College of MedicineClass of 2014
Certifications & Licensure
MN State Medical License 2016 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 4 citationsEffects of Electronic Medical Record Display on Provider Ordering Behavior: Leveraging the EMR to Improve Quality and CostsMichael Schnaus, Michael Michalik, Paula K. Skarda
The American Journal of Medicine. 2017-12-01 - 18 citationsOral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis.K Gary Barnette, Michael S Gordon, Domingo Rodriguez, T Gary Bird, Alan Skolnick
NEJM Evidence. 2022-09-01 - 46 citationsAuxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial.Joseph B Miller Md, Charles A. Bruen, Michael Schnaus, Jeffrey Zhang, Sadia Ali
Critical Care. 2020-08-14
Press Mentions
Veru Announces Presentation of Phase 3 Study of Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome at the 11th International Conference on Emerging Infectious Diseases (ICEID) on August 7-10, 2022August 9th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
